Medline enters the analysis with 23% upside to the analyst price target and a 3.3-to-1 favorable risk/reward — supported by consecutive earnings beats and a near-perfect Piotroski financial-health score — but heavy reliance on three group-purchasing organizations for approximately 69% of revenues remains the central concentration risk.
Thesis pillars
- Gpo Customer Concentration Risk↑Improving
- Material Upside Favorable Risk Reward↓Deteriorating
- Early Earnings Beat Consistency↑Improving
- +1 more pillar — see the Why tab for full reasoning
Pillars as of Jul 3, 2026, based on the 10-K filed Feb 25, 2026· older than 90 days
Medline Inc. (MDLN) Stock Analysis
Momentum Cont setup
Healthcare · Medical Instruments & Supplies
Hold if already holding. Not a fresh buy at $40.35, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); Analyst target reached - limited upside remaining.
Medline, founded in 1966, is the largest provider of med-surg products by total net sales, distributing approximately 335,000 products through Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute facilities globally.... Read more
Hold if already holding. Not a fresh buy at $40.35, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); Analyst target reached - limited upside remaining. Chart setup: Trend continuation, RSI 64, MACD bullish. Mixed signals. Hold existing position. Score 5.8/10, moderate confidence.
Passes 6/9 gates (positive momentum, no SEC red flags, news boost analyst 0.50, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and clean insider activity. Suitability: moderate.
Recent developments
updated Nov 1, 2026Recent Developments — Medline Inc.
Latest news
- NEWS Medline $MDLN Stock: Oppenheimer & Co. Inc. Grows Position - MarketBeat — MarketBeat Nov 1, 2026 neutral
- NEWS Medline (NASDAQ:MDLN) Reaches New 12-Month Low - What's Next? - MarketBeat — MarketBeat Oct 30, 2026 negative
- NEWS $MDLN Stock Market Alert: Medline Investigated for - GlobeNewswire — GlobeNewswire Oct 28, 2026 negative
- NEWS INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medline Inc. - MDLN - FinancialContent — FinancialContent Oct 27, 2026 negative
- NEWS Medline (MDLN) Q2 2026 Results: Profit Per Share Clears Its Benchmark in Latest Trading - vinanet.vn — vinanet.vn Aug 26, 2026 positive
Latest item Nov 1, 2026 · Generated 2026-11-05T11:44:08Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerVizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs)69%10-K Item 1A: 'approximately $19.7 billion (or 69% of consolidated net sales ... contract with our largest GPOs: Vizient Supply, LLC, HealthTrust Purchasing Group, L.P., and Premier Healthcare Alliance, L.P.'
- LOWCustomertop five U.S. customers11%10-K Item 1A: 'our top five U.S. customers represented approximately $3.2 billion (or 11.3%) of our net sales'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $40.35, but acceptable to hold if already in. Reasons: Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); Analyst target reached - limited upside remaining. Chart setup: Trend continuation, RSI 64, MACD bullish. Mixed signals. Hold existing position. Analyst target $39.88 reached (−1.2%), stop $37.53 (−7.5%), A.R:R -0.1:1. Score 5.8/10, moderate confidence.
Analyst target $39.88 reached (−1.2% from $40.35); no take-profit level is published. Analyst target $39.88 reached (−1.2%), stop $37.53 (−7.5%), A.R:R -0.1:1. Stop-loss: $37.53.
Concentration risk — Customer: Vizient Supply, HealthTrust Purchasing Group, and Premier Healthcare Alliance (GPOs) (69.0%); Analyst target reached - limited upside remaining; V7 low-quality RISK_OFF penalty: -0.5 (Q=4.2).
Medline Inc. trades at a P/E of 91.7 (forward 25.7). TrendMatrix value score: 5.1/10. Verdict: Hold.
34 analysts rate MDLN, with a consensus score of 4.1/5. 26 analysts publish price targets averaging $44.
What does Medline Inc. do?Medline, founded in 1966, is the largest provider of med-surg products by total net sales, distributing approximately...
Medline, founded in 1966, is the largest provider of med-surg products by total net sales, distributing approximately 335,000 products through Medline Brand and Supply Chain Solutions segments to hospitals, surgery centers, physician offices, and post-acute facilities globally. Prime Vendor agreements generated $18.0 billion (63.4% of net sales) in 2025; the company operates 70 global distribution centers and 2,100+ owned MedTrans trucks, employing over 45,000 people.